Open Access iconOpen Access

ARTICLE

crossmark

Immunocytochemical examination of PTEN and Ki-67 for endometrial carcinoma using thin-layer endometrial preparations

by Xi Yang1, Ke Ma1,*, Rui Chen1, Naiyi Zhang2, Yiting Meng3, Jia Wen1, Qinping Liao1

1 Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, Medical Center of Tsinghua University, Beijing, 102218, China
2 Department of Gynecology, Beijing Cancer Hospital, Beijing, 100142, China
3 Department of Pathology, Beijing Tsinghua Changgung Hospital, Medical Center of Tsinghua University, Beijing, 102218, China

* Address correspondence to: Ke Ma, email

BIOCELL 2021, 45(4), 923-932. https://doi.org/10.32604/biocell.2021.013625

Abstract

The current study is designed to evaluate certain immunocytochemical (ICC) biomarkers to gain a better cytodiagnosis. For this purpose, 85 patients from March 2016 to March 2019 who planned to get a hysteroscopy assay were recruited. Cytological sampling was conducted by scratching the uterus cavity using SAP-1, and the samples were processed as liquid-based smears, using SurePath technology. 36 patients diagnosed with EC or atypical endometrial hyperplasia were recruited in this study. 33 cases were diagnosed with EC, and 3 cases were diagnosed with atypical endometrial hyperplasia, allocated with EC or precancerous lesions group. 26 cases were diagnosed with benign lesions group. Among these cases, 9 cases were diagnosed with endometrial simple hyperplasia, 2 cases were diagnosed with complicated hyperplasia, 5 cases were diagnosed with an irregular proliferation of endometrium and 10 cases were diagnosed with endometrial polyps. There were 23 cases in the healthy group. Staining in thin-layer endometrial preparations by ICC and using H-score or counting the percentage of stained cells. The presentation of PTEN in normal endometrium, benign lesions, and EC/precancerous lesions were different (p < 0.01). Taking the cut-off value of 50 (Youden’s index: 0.698) PTEN expression for the diagnosis of EC/precancerous lesion, the sensitivity and specificity were 83.7% and 86.1%. The presentation of Ki-67 in normal endometrium, benign lesions, and EC/precancerous lesions were different (p < 0.01). Taking the cut-off value of 15% (Youden’s index: 0.76) Ki-67 expression for the diagnosis of EC/precancerous lesion, the sensitivity and specificity were 94.4% and 81.6%. In this study, the use of different cut-off values for Ki-67 and PTEN helped differentiate endometrial lesions. Immunocytochemistry in the ECT detection of PTEN and Ki-67 can improve the diagnostic capabilities of endometrial cancer and precancerous lesions.

Keywords


Cite This Article

APA Style
YANG, X., MA, K., CHEN, R., ZHANG, N., MENG, Y. et al. (2021). Immunocytochemical examination of PTEN and ki-67 for endometrial carcinoma using thin-layer endometrial preparations. BIOCELL, 45(4), 923-932. https://doi.org/10.32604/biocell.2021.013625
Vancouver Style
YANG X, MA K, CHEN R, ZHANG N, MENG Y, WEN J, et al. Immunocytochemical examination of PTEN and ki-67 for endometrial carcinoma using thin-layer endometrial preparations. BIOCELL . 2021;45(4):923-932 https://doi.org/10.32604/biocell.2021.013625
IEEE Style
X. YANG et al., “Immunocytochemical examination of PTEN and Ki-67 for endometrial carcinoma using thin-layer endometrial preparations,” BIOCELL , vol. 45, no. 4, pp. 923-932, 2021. https://doi.org/10.32604/biocell.2021.013625

Citations




cc Copyright © 2021 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2228

    View

  • 1466

    Download

  • 0

    Like

Share Link